[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336038-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336038-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bioinformatics-analysis-and-clinical-significance-of-nrp-1-in-triple-negative-breast-cancer","Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer","","Purpose: Investigate the diagnostic and prognostic value of neuropilin-1 (NRP-1) in triple-negative breast cancer (TNBC) and characterize its immune-related functions within the tumor microenvironment. Methods: Integrate TCGA, GEO, GTEx, ImmuCellAI, Reactome, and drug-sensitivity datasets, and validate using TNBC tumor tissues (50 patients) and adjacent noncancer tissues (10 patients) with bioinformatics plus immunohistochemistry. Results: NRP-1 differs between tumor and noncancer tissues, associates with immune regulation, and predicts poorer survival. Conclusion: NRP-1 supports biomarker and therapeutic targeting in TNBC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bioinformatics-analysis-and-clinical-significance-of-nrp-1-in-triple-negative-breast-cancer/336038/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bioinformatics-analysis-and-clinical-significance-of-nrp-1-in-triple-negative-breast-cancer/336038.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study purpose regarding NRP-1 in TNBC?","Question",{"text":63,"@type":64},"To evaluate whether NRP-1 has diagnostic and prognostic value in triple-negative breast cancer and to analyze its immune function in the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were NRP-1 relationships with clinical and immune features assessed?",{"text":68,"@type":64},"The study combined bioinformatics using multiple public cancer and immune-related databases with immunohistochemistry on collected TNBC and adjacent noncancer tissue samples.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings about NRP-1 expression and patient prognosis?",{"text":72,"@type":64},"NRP-1 gene expression was significantly higher in cancer versus noncancer tissues, and high NRP-1 expression was linked to worse survival outcomes and immune-related activity in TNBC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336038,1790749755,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Heliyon 10 (2024) e27368  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Research article\u003Cbr>Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer\u003Cbr>Xiao Maa, Haonan Liu a, Congcong Shi b, Yang Zhao a, Hongmei Wang a, Zhengxiang Hana, *\u003Cbr>a Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China b Department of Gastroenterology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: Biomarkers Immune infiltrates NRP-1\u003Cbr>Therapeutic targets\u003Cbr>Triple-negative breast cancer tumor purity |  | Purpose: This study aimed to investigate the diagnostic and prognostic values of neuropilin-1 (NRP-1) in triple-negative breast cancer (TNBC) and analyze its immune function in the tumor microenvironment.\u003Cbr>Methods: Based on The Cancer Genome Atlas (TCGA), Gene Expression Omnibus, Genotype Tissue Expression, Immune Cell Abundance Identifier (ImmuCellAI), Reactome, and Genomics of Drug Sensitivity in Cancer databases, the cancer tissues from 50 patients with TNBC and corresponding adjacent noncancerous tissues from 10 patients (tissue microarrays were purchased from Shanghai Xinchao Biotechnology Co., Ltd.) were collected for validation. Bioinformatics combined with immunohistochemistry was used to analyze the relationship among NRP-1 expression, prognosis, tumor immune cell infiltration, immune genes, and drug resistance so as to investigate the role of NRP-1 in the development of TNBC.\u003Cbr>Results: A significant difference in NRP-1 gene expression was found between the cancerous and noncancerous tissues (p-value \u003C 0.05); NRP-1 expression was high in carcinoma. No significant correlation was found between NRP-1 protein expression levels and each stage in the TCGA database. Prognostic expression survival analysis showed that the survival probability of patients with high NRP-1 expression was significantly lower than that of patients with low NRP-1 expression (p-value \u003C 0.05), suggesting that the gene might be a pro-oncogene. The data from 50 clinical samples also confirmed that the NRP-1 expression was significantly higher in triplenegative breast cancer (TNBC) tissues than in adjacent noncancerous tissues. The NRP-1 expression significantly correlated with the tumor diameter and pathological grade (p-value \u003C 0.05), but not with age, stage, and ki67 (p-value > 0.05). The Kaplan–Meier survival curves suggested that the median overall survival was significantly shorter in patients with high NRP-1 expression than in those with low NRP-1 expression (13.6 months vs 15.2 months, p-value \u003C 0.05). The 300 genes most significantly positively associated with this gene were selected for Gene Ontology (including Biological Process, Molecular Function, and Cellular Component groups) and Kyoto Encyclopedia of Genes and Genomics enrichment analysis. The findings showed that NRP-1 was involved in immune regulation in TNBC. In addition, the NRP-1 expression in TNBC positively correlated with a variety of immune cells and checkpoints. Conclusion: NRP-1 can be used as a potential biomarker and therapeutic target in TNBC. |\n\n* Corresponding author.  \n[E-mail address:](E-mail address: wrh2133@163.com)[ wrh2133@163.com](E-mail address: wrh2133@163.com) (Z. Han).  \n[https://doi.org/10.1016/j.heliyon.2024.e27368](https://doi.org/10.1016/j.heliyon.2024.e27368)  \nReceived 8 May 2023; Received in revised form 21 February 2024; Accepted 28 February 2024 Available online 6 March 2024  \n2405-8440/© 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)).  \n1. Introduction  \nBreast cancer is the leading ca","cbCaipblHHa7fZZa","https://ap.wps.com/l/cbCaipblHHa7fZZa","pdf",16143120,16,"English","# Introduction\n# Materials and methods\n## The Cancer Genome Atlas database\n# Results\n# Discussion\n# Conclusion","[{\"question\":\"What is the study purpose regarding NRP-1 in TNBC?\",\"answer\":\"To evaluate whether NRP-1 has diagnostic and prognostic value in triple-negative breast cancer and to analyze its immune function in the tumor microenvironment.\"},{\"question\":\"How were NRP-1 relationships with clinical and immune features assessed?\",\"answer\":\"The study combined bioinformatics using multiple public cancer and immune-related databases with immunohistochemistry on collected TNBC and adjacent noncancer tissue samples.\"},{\"question\":\"What were the key findings about NRP-1 expression and patient prognosis?\",\"answer\":\"NRP-1 gene expression was significantly higher in cancer versus noncancer tissues, and high NRP-1 expression was linked to worse survival outcomes and immune-related activity in TNBC.\"}]","Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer | PDF",1790013312]